# Week 8: L‚ÇÇ Clinical Protocol DSL - Architecture & Implementation Plan

## Vision

Transform MedLang from a modeling DSL into a **clinical trial design language** by adding an L‚ÇÇ protocol layer that enables clinicians to specify:

- Trial arms (treatment regimens)
- Visit schedules
- Inclusion/exclusion criteria
- Clinical endpoints (ORR, PFS, OS)

Built on top of the mechanistic PBPK-QSP-QM models from Weeks 1-7.

## Architecture Overview

```
‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê
‚îÇ  L‚ÇÇ Protocol Layer (Week 8)                             ‚îÇ
‚îÇ  ‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê  ‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê  ‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê             ‚îÇ
‚îÇ  ‚îÇ Protocol  ‚îÇ  ‚îÇ  Arms   ‚îÇ  ‚îÇ Endpoints ‚îÇ             ‚îÇ
‚îÇ  ‚îÇ   Spec    ‚îÇ  ‚îÇ         ‚îÇ  ‚îÇ (ORR,PFS) ‚îÇ             ‚îÇ
‚îÇ  ‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚î¨‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò  ‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚î¨‚îÄ‚îÄ‚îÄ‚îÄ‚îò  ‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚î¨‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò             ‚îÇ
‚îÇ        ‚îÇ             ‚îÇ              ‚îÇ                    ‚îÇ
‚îÇ        ‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚î¥‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò                    ‚îÇ
‚îÇ                      ‚îÇ                                   ‚îÇ
‚îÇ              Instantiate per arm                         ‚îÇ
‚îÇ                      ‚Üì                                   ‚îÇ
‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îº‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò
                       ‚îÇ
‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îº‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê
‚îÇ  L‚ÇÅ Mechanistic Layer (Weeks 1-7)                        ‚îÇ
‚îÇ                      ‚Üì                                   ‚îÇ
‚îÇ  ‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê                ‚îÇ
‚îÇ  ‚îÇ  Timeline (per arm)                  ‚îÇ                ‚îÇ
‚îÇ  ‚îÇ  - Dosing: 200mg QD vs 400mg QD      ‚îÇ                ‚îÇ
‚îÇ  ‚îÇ  - Visits: baseline, C1, C2, FU      ‚îÇ                ‚îÇ
‚îÇ  ‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚î¨‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò                ‚îÇ
‚îÇ               ‚îÇ                                          ‚îÇ
‚îÇ               ‚Üì                                          ‚îÇ
‚îÇ  ‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê                ‚îÇ
‚îÇ  ‚îÇ  Cohort (filtered by inclusion)      ‚îÇ                ‚îÇ
‚îÇ  ‚îÇ  - Age 18-75                          ‚îÇ                ‚îÇ
‚îÇ  ‚îÇ  - ECOG 0-1                           ‚îÇ                ‚îÇ
‚îÇ  ‚îÇ  - Baseline tumor ‚â• 50 cm¬≥           ‚îÇ                ‚îÇ
‚îÇ  ‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚î¨‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò                ‚îÇ
‚îÇ               ‚îÇ                                          ‚îÇ
‚îÇ               ‚Üì                                          ‚îÇ
‚îÇ  ‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê                ‚îÇ
‚îÇ  ‚îÇ  Population Model                    ‚îÇ                ‚îÇ
‚îÇ  ‚îÇ  Oncology_PBPK_QSP (with QM stub)    ‚îÇ                ‚îÇ
‚îÇ  ‚îÇ  - PBPK: A_plasma, A_tumor           ‚îÇ                ‚îÇ
‚îÇ  ‚îÇ  - QSP: Tumour volume                ‚îÇ                ‚îÇ
‚îÇ  ‚îÇ  - QM: Kd ‚Üí EC50, ŒîG ‚Üí Kp_tumor      ‚îÇ                ‚îÇ
‚îÇ  ‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò                ‚îÇ
‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò
```

## Week 8 Progress

### ‚úÖ Completed

1. **AST Extensions** (`compiler/src/ast/mod.rs`)
   - `ProtocolDef` - Top-level protocol container
   - `ArmDef` - Treatment arm specification (label, dose)
   - `VisitDef` - Visit schedule (name, time)
   - `InclusionDef` - Inclusion criteria clauses
   - `EndpointDef` - Clinical endpoint specifications
   - `EndpointKind` - Binary vs TimeToEvent
   - `EndpointSpec` - ResponseRate and TimeToProgression specs
   - Added `Declaration::Protocol` variant

2. **Lexer Tokens** (`compiler/src/lexer.rs`)
   - `protocol`, `arms`, `visits`, `inclusion`, `endpoints`
   - `between` (for age ranges)
   - Display implementations

3. **Type Checker** (`compiler/src/typeck.rs`)
   - Added Protocol handling (placeholder for Week 8 completion)

4. **Example Protocol** (`docs/examples/oncology_phase2_protocol.medlang`)
   - 2-arm Phase 2 oncology trial
   - Visit schedule (baseline ‚Üí followup)
   - Inclusion criteria (age, ECOG, baseline tumor)
   - ORR endpoint specification

### üöß Remaining Implementation

#### 1. Parser Support (`compiler/src/parser.rs`)

Need to add:

```rust
fn protocol_def(input: TokenSlice) -> IResult<TokenSlice, ProtocolDef> {
    // Parse: protocol Name { ... }
}

fn arms_block(input: TokenSlice) -> IResult<TokenSlice, Vec<ArmDef>> {
    // Parse: arms { ArmA { label = "..."; dose = 200.0_mg; } ... }
}

fn visits_block(input: TokenSlice) -> IResult<TokenSlice, Vec<VisitDef>> {
    // Parse: visits { baseline at 0.0_d; cycle1 at 28.0_d; ... }
}

fn inclusion_block(input: TokenSlice) -> IResult<TokenSlice, InclusionDef> {
    // Parse: inclusion { age between 18_y and 75_y; ... }
}

fn endpoints_block(input: TokenSlice) -> IResult<TokenSlice, Vec<EndpointDef>> {
    // Parse: endpoints { ORR { type = "binary"; ... } }
}
```

**Parsing strategy:**
- Reuse existing expression parsers for values
- Use block-based parsing similar to `model { }`
- Handle unit literals (200.0_mg, 28.0_d, etc.)

#### 2. IR Layer (`compiler/src/ir.rs` - new structs)

```rust
pub struct IRProtocol {
    pub name: String,
    pub population_model_name: String,
    pub arms: Vec<IRArm>,
    pub visits: Vec<IRVisit>,
    pub inclusion: Option<IRInclusion>,
    pub endpoints: Vec<IREndpoint>,
}

pub struct IRArm {
    pub name: String,
    pub label: String,
    pub dose_mg: f64,
}

pub struct IRVisit {
    pub name: String,
    pub time_days: f64,
}

pub struct IRInclusion {
    pub age_range: Option<(u32, u32)>,
    pub ecog_allowed: Option<Vec<u8>>,
    pub baseline_tumour_min_cm3: Option<f64>,
}

pub enum IREndpointSpec {
    ResponseRate {
        observable: String,
        shrink_fraction: f64,
        window_start_days: f64,
        window_end_days: f64,
    },
}
```

**Lowering:** AST `ProtocolDef` ‚Üí IR `IRProtocol`
- Extract all fields
- Convert unit literals to canonical units (days, mg, etc.)

#### 3. Protocol ‚Üí Timeline Instantiation (`compiler/src/protocol.rs` - new module)

```rust
pub struct ArmStudy {
    pub arm: IRArm,
    pub timeline: IRTimeline,
    pub cohort: IRCohort,
}

pub fn instantiate_arm_timeline(
    protocol: &IRProtocol,
    arm: &IRArm,
) -> Result<IRTimeline, ProtocolError> {
    // 1. Create dose events at t=0 with arm.dose_mg
    // 2. Create observation events at each visit time
    // 3. Return IRTimeline for this arm
}

pub fn create_arm_cohort(
    protocol: &IRProtocol,
    arm: &IRArm,
    n_subjects: usize,
) -> Result<IRCohort, ProtocolError> {
    // 1. Reference the population model
    // 2. Reference the arm's timeline
    // 3. Apply inclusion criteria as filters
}
```

#### 4. Endpoint Evaluation (`compiler/src/endpoints.rs` - new module)

```rust
pub struct SubjectTrajectory {
    pub subject_id: usize,
    pub times: Vec<f64>,
    pub tumour_volume: Vec<f64>,
    pub baseline_tumour: f64,
}

pub fn compute_orr(
    spec: &IREndpointSpec,
    trajectories: &[SubjectTrajectory],
) -> EndpointResult {
    match spec {
        IREndpointSpec::ResponseRate { shrink_fraction, .. } => {
            let responders: Vec<bool> = trajectories.iter().map(|traj| {
                let baseline = traj.baseline_tumour;
                let min_vol = traj.tumour_volume.iter().copied()
                    .fold(f64::INFINITY, f64::min);
                
                // Response = ‚â•30% shrinkage
                (baseline - min_vol) / baseline >= *shrink_fraction
            }).collect();
            
            let orr = responders.iter().filter(|&&r| r).count() as f64 
                    / responders.len() as f64;
            
            EndpointResult::Binary { value: orr }
        },
        _ => unimplemented!("PFS in Week 9"),
    }
}

pub enum EndpointResult {
    Binary { value: f64 },       // ORR
    TimeToEvent { median: f64 }, // PFS
}
```

#### 5. CLI Commands (`compiler/src/bin/mlc.rs`)

```rust
// New commands:

// 1. Compile protocol (debugging)
mlc compile-protocol examples/oncology_phase2_protocol.medlang -o protocol.json

// 2. Simulate virtual trial
mlc simulate-protocol \
    examples/oncology_phase2_protocol.medlang \
    --qm-stub data/lig001_qm_stub.json \
    --n-subjects 200 \
    --out results/phase2_sim.json
```

**Implementation:**

```rust
fn simulate_protocol_command(
    protocol_file: &Path,
    qm_stub_file: Option<&Path>,
    n_subjects: usize,
    output: &Path,
) -> Result<(), Error> {
    // 1. Parse protocol
    let protocol_ast = parse_protocol_file(protocol_file)?;
    let ir_protocol = lower_protocol(&protocol_ast)?;
    
    // 2. Load QM stub
    let qm_stub = qm_stub_file.map(|p| QuantumStub::load(p)).transpose()?;
    
    // 3. For each arm:
    let mut arm_results = Vec::new();
    for arm in &ir_protocol.arms {
        // 3a. Instantiate timeline and cohort
        let timeline = instantiate_arm_timeline(&ir_protocol, arm)?;
        let cohort = create_arm_cohort(&ir_protocol, arm, n_subjects)?;
        
        // 3b. Simulate subjects (reuse existing simulation)
        let trajectories = simulate_cohort(
            &ir_protocol.population_model_name,
            &timeline,
            &cohort,
            qm_stub.as_ref(),
        )?;
        
        // 3c. Apply inclusion filters
        let included = apply_inclusion_criteria(
            trajectories,
            &ir_protocol.inclusion,
        );
        
        // 3d. Compute endpoints
        let orr = compute_orr(
            &ir_protocol.endpoints[0].spec, // First endpoint
            &included,
        )?;
        
        arm_results.push(ArmResult {
            arm_name: arm.name.clone(),
            label: arm.label.clone(),
            n_included: included.len(),
            orr,
        });
    }
    
    // 4. Write JSON output
    serde_json::to_writer_pretty(
        File::create(output)?,
        &TrialResults { arms: arm_results },
    )?;
    
    Ok(())
}
```

## Example Output

Running:
```bash
mlc simulate-protocol \
    oncology_phase2_protocol.medlang \
    --qm-stub lig001_egfr_qm.json \
    --n-subjects 200
```

Would produce:
```json
{
  "protocol": "Oncology_Phase2",
  "population_model": "Oncology_PBPK_QSP_Pop",
  "qm_stub": "LIG001 ‚Üí EGFR",
  "arms": [
    {
      "name": "ArmA",
      "label": "200 mg QD",
      "dose_mg": 200.0,
      "n_randomized": 200,
      "n_included": 178,
      "endpoints": {
        "ORR": {
          "type": "binary",
          "value": 0.35,
          "95_ci": [0.28, 0.42]
        }
      }
    },
    {
      "name": "ArmB",
      "label": "400 mg QD",
      "dose_mg": 400.0,
      "n_randomized": 200,
      "n_included": 181,
      "endpoints": {
        "ORR": {
          "type": "binary",
          "value": 0.48,
          "95_ci": [0.41, 0.55]
        }
      }
    }
  ],
  "comparison": {
    "delta_ORR": 0.13,
    "p_value": 0.012
  }
}
```

## Testing Strategy

1. **Parser tests** (`tests/protocol_parser_test.rs`)
   - Parse arms block
   - Parse visits block
   - Parse inclusion criteria
   - Parse endpoints
   - Full protocol round-trip

2. **IR tests** (`tests/protocol_ir_test.rs`)
   - AST ‚Üí IR lowering
   - Unit conversion (mg, days, etc.)
   - Validation (dose > 0, times increasing, etc.)

3. **Endpoint tests** (`tests/endpoint_evaluation_test.rs`)
   - Synthetic trajectories with known ORR
   - Edge cases (all responders, none, missing data)

4. **Integration tests** (`tests/protocol_integration_test.rs`)
   - Full protocol ‚Üí timelines instantiation
   - Simulated trial with known parameters
   - Endpoint computation

## Design Decisions

### 1. Keep L‚ÇÇ Separate from L‚ÇÅ

Protocol layer is **compositional**, not invasive:
- Protocols reference existing population models
- No changes to core MedLang-D semantics
- Clean separation: `protocol.rs`, `endpoints.rs`

### 2. Limited Scope for Week 8

Focus on **one working vertical slice**:
- ‚úÖ ORR endpoint (binary)
- ‚ùå PFS (defer to Week 9)
- ‚úÖ Simple inclusion (age, ECOG, baseline tumor)
- ‚ùå Complex eligibility (biomarkers, prior therapy)

### 3. Deterministic Simulation First

Week 8 focuses on **virtual trials** with mechanistic model:
- Fixed population parameters (no uncertainty yet)
- Simulate N subjects per arm
- Compute endpoint statistics

Week 9+ can add:
- Bayesian uncertainty in population parameters
- Power calculations
- Adaptive designs

## Next Steps (Week 9 Options)

After completing Week 8, natural extensions:

### Option A: Time-to-Event Endpoints (PFS/OS)

- Add `TimeToProgression` endpoint evaluation
- Implement Kaplan-Meier estimation
- Log-rank tests for arm comparison
- Hazard ratio calculation

### Option B: FHIR/CQL Export

- Map `ProtocolDef` to FHIR PlanDefinition
- Generate CQL inclusion criteria
- Export to standard clinical trial formats

### Option C: Bayesian Trial Design

- Treat population parameters as uncertain
- Add prior elicitation from QM + literature
- Implement operating characteristics
- Adaptive randomization

## Summary

Week 8 establishes MedLang as a **clinical trial design language** by adding an L‚ÇÇ protocol layer that:

1. **Specifies** trial structure (arms, visits, criteria, endpoints)
2. **Instantiates** per-arm timelines from protocol spec
3. **Simulates** virtual patients with mechanistic PBPK-QSP-QM model
4. **Evaluates** clinical endpoints (ORR, with PFS coming in Week 9)

This transforms MedLang from "mechanistic model compiler" to "complete clinical development platform" connecting molecular physics to patient outcomes.

## Files Created/Modified

### Created
- `compiler/src/endpoints.rs` (new module - to implement)
- `compiler/src/protocol.rs` (new module - to implement)
- `docs/examples/oncology_phase2_protocol.medlang` (example)
- `docs/week8_architecture.md` (this document)

### Modified
- `compiler/src/ast/mod.rs` (+80 lines) - Protocol AST structures
- `compiler/src/lexer.rs` (+20 lines) - Protocol tokens
- `compiler/src/typeck.rs` (+1 line) - Protocol type checking stub
- `compiler/src/parser.rs` (to be modified) - Protocol parsing
- `compiler/src/ir.rs` (to be modified) - Protocol IR
- `compiler/src/bin/mlc.rs` (to be modified) - CLI commands

### Test Files (to be created)
- `tests/protocol_parser_test.rs`
- `tests/protocol_ir_test.rs`
- `tests/endpoint_evaluation_test.rs`
- `tests/protocol_integration_test.rs`
